Byoma is raising the bar for clinical efficacy in skincare with science-backed solutions that meet unmet consumer needs. Byoma Blemish marks a new era of acne care that is an effective, barrier-first treatment you can trust for long-term skin health.

The new Blemish system targets breakouts at every stage while protecting the skin’s barrier. It is powered by patent-pending Clearamide Complex and Salicylic Acid and clinically proven to deliver results without damage or irritation.

Rather than relying on Benzoyl Peroxide and Salicylic Acid, the BYOMA Blemish system takes a barrier-first approach to blemish treatment.

The Clearamide Complex includes Ceramide NP, Phytosphingosine, Ethyl Linoleate, Hydroxycinnamic Acid, and Rutin.

Byoma Blemish features a four-step face solution and two body products to target all types of acne.

Face care solutions include an Acne Clearing Cleanser, Redness Relief Soothing Toner, Acne Treatment Spot Paste, and an Acne Control Moisturizer. 

Byoma also offers an Acne Clearing Body Wash and Acne Clearing Body Lotion. 

Every Byoma product undergoes at least two independent clinical trials, with over $2 million invested in research, over 75 trials completed, and over 130,000 skin measurements captured.

Read Next

Bansk Group Acquires Majority Stake in Byoma

Byoma Promotes Skin Barrier Awareness Month with a New Campaign

Byoma Launches Ultralight Face Fluid SPF50